MariMed Closes $58.7 Million Debt Refinancing
10-Year Term at Reduced Annualized Interest Rate Will Result in $4.7 Million Reduction to Principal and Interest Expense in the First 12 Months and $3.5 Million Annually for Next Four Years and Includes No Equity Component 10-Year Term at Reduced Annualized I…
NORWOOD, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) — MariMed Inc. (MariMed or the Company) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, announ…